Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

Daniele, G; Lorusso, D; Scambia, G; Cecere, Sc; Nicoletto, Mo; Breda, E; Colombo, N; Artioli, G; Cannella, L; Lo Re, G; Raspagliesi, F; Maltese, G; Salutari, V; Ferrandina, G; Greggi, S; Baldoni, A; Bergamini, A; Piccirillo, Mc; Tognon, G; Floriani, I; Signoriello, S; Perrone, F; Pignata, S.